← Open Payments lookup

MAGHAN ASHMORE: Open Payments

NPI 1720624430 · CLEVELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$460 in 23 payments from 8 companies in 2025. Trend: 2023 $339 · 2024 $580 · 2025 $460

Food & beverage: $460
CompanyPaymentsAmount
Novo Nordisk Inc10$159
Alpha Cognition USA, Inc.1$68
Lilly USA, LLC3$62
Dexcom, Inc.2$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
ABBVIE INC.2$37
AstraZeneca Pharmaceuticals LP2$31
Ardelyx, Inc.1$28

Products named: Ozempic, Zunveyl, Rybelsus, Dexcom G6 Transmitter, MOUNJARO, UBRELVY, IBSRELA, JARDIANCE.

Industry payments across MS — which companies pay providers there.